Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||
net income | 105,000,000 | 80,000,000 | 56,000,000 | 32,000,000 | 56,000,000 | 14,000,000 | -83,000,000 | -36,000,000 | -31,000,000 | -98,000,000 | -81,000,000 | -100,000,000 | -98,000,000 | -54,000,000 | -23,000,000 | 147,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||
depreciation and amortization | 13,000,000 | 16,000,000 | 19,000,000 | 11,000,000 | 12,000,000 | 12,000,000 | 11,000,000 | 10,000,000 | 8,000,000 | 8,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 6,000,000 | 5,383,000 |
stock-based compensation expense | 66,000,000 | 60,000,000 | 60,000,000 | 60,000,000 | 60,000,000 | 67,000,000 | 66,000,000 | 71,000,000 | 71,000,000 | 72,000,000 | 63,000,000 | 61,000,000 | 57,000,000 | |||
amortization of deferred contract acquisition costs | 25,000,000 | 25,000,000 | 23,000,000 | 23,000,000 | 21,000,000 | 19,000,000 | 19,000,000 | |||||||||
change in fair value of warrant liability | -7,000,000 | 8,000,000 | -3,000,000 | 12,000,000 | 0 | 1,000,000 | 36,000,000 | -8,000,000 | -18,000,000 | 26,000,000 | -3,000,000 | |||||
credit loss expense | 26,000,000 | 18,000,000 | 22,000,000 | 20,000,000 | 18,000,000 | 17,000,000 | 15,000,000 | 20,000,000 | 19,000,000 | 12,000,000 | 13,000,000 | 16,000,000 | 11,000,000 | 4,000,000 | 3,000,000 | |
stock-based charitable contribution expense | 0 | 0 | ||||||||||||||
asset impairments | 3,000,000 | 1,000,000 | 0 | 0 | ||||||||||||
gain on warrant extinguishment | 0 | |||||||||||||||
other non-cash items | -2,000,000 | -2,000,000 | -1,000,000 | -2,000,000 | 1,000,000 | 3,000,000 | ||||||||||
changes in operating assets and liabilities: | ||||||||||||||||
accounts receivable | -4,000,000 | -7,000,000 | -9,000,000 | -18,000,000 | -9,000,000 | -23,000,000 | -22,000,000 | 18,000,000 | -22,000,000 | -20,000,000 | -15,000,000 | -13,000,000 | -2,000,000 | |||
other current assets | -12,000,000 | 2,000,000 | -12,000,000 | -4,000,000 | 3,000,000 | 5,000,000 | -19,000,000 | |||||||||
deferred contract acquisition costs | -36,000,000 | -40,000,000 | -33,000,000 | -35,000,000 | -32,000,000 | -33,000,000 | -30,000,000 | |||||||||
inventories | -1,000,000 | 8,000,000 | 7,000,000 | 4,000,000 | 10,000,000 | -2,000,000 | -20,000,000 | 9,000,000 | 5,000,000 | -1,000,000 | -15,000,000 | -33,000,000 | -18,000,000 | -2,000,000 | -3,664,000 | |
accounts payable | -2,000,000 | 3,000,000 | 10,000,000 | 6,000,000 | -3,000,000 | -14,000,000 | 16,000,000 | 4,000,000 | -15,000,000 | 6,000,000 | 6,000,000 | 1,000,000 | -8,000,000 | 8,000,000 | -12,000,000 | 6,793,000 |
accrued expenses and other current liabilities | -20,000,000 | 53,000,000 | -56,000,000 | 55,000,000 | -8,000,000 | 38,000,000 | -37,000,000 | 64,000,000 | -7,000,000 | 44,000,000 | -20,000,000 | 25,000,000 | 15,000,000 | 37,000,000 | 39,000,000 | 38,694,000 |
deferred revenue | 4,000,000 | 3,000,000 | -1,000,000 | 0 | -1,000,000 | 13,000,000 | 11,000,000 | -11,000,000 | -1,000,000 | 4,000,000 | 3,000,000 | -2,000,000 | -5,000,000 | 2,000,000 | -6,000,000 | -3,484,000 |
operating lease right-of-use assets and operating lease liabilities | -5,000,000 | -3,000,000 | ||||||||||||||
other assets and liabilities | 0 | -5,000,000 | -4,000,000 | -1,000,000 | -1,000,000 | -2,000,000 | 1,000,000 | -4,000,000 | 2,000,000 | -2,000,000 | -4,000,000 | 0 | -6,000,000 | -4,000,000 | -3,000,000 | -3,068,000 |
net cash from operating activities | 165,000,000 | 223,000,000 | 79,000,000 | 147,000,000 | 109,000,000 | 124,000,000 | -20,000,000 | 92,000,000 | 48,000,000 | 50,000,000 | -55,000,000 | -19,000,000 | -69,000,000 | -21,000,000 | -47,000,000 | -31,970,000 |
cash flows from investing activities: | ||||||||||||||||
capital expenditures | -12,000,000 | -15,000,000 | -10,000,000 | -13,000,000 | -12,000,000 | -16,000,000 | -13,000,000 | |||||||||
free cash flows | 153,000,000 | 208,000,000 | 69,000,000 | 134,000,000 | 97,000,000 | 108,000,000 | -33,000,000 | |||||||||
purchases of marketable securities | -90,000,000 | -171,000,000 | -110,000,000 | -120,000,000 | -77,000,000 | -131,000,000 | -145,000,000 | -144,000,000 | -128,000,000 | -175,000,000 | -176,000,000 | -247,000,000 | -47,000,000 | -110,000,000 | -30,000,000 | |
proceeds from the sale of marketable securities | 38,000,000 | 57,000,000 | 40,000,000 | 46,000,000 | 27,000,000 | 35,000,000 | 18,000,000 | 12,000,000 | 10,000,000 | 6,000,000 | 7,000,000 | 5,000,000 | 9,000,000 | 14,000,000 | 18,000,000 | |
maturities of marketable securities | 60,000,000 | 91,000,000 | 102,000,000 | 72,000,000 | 71,000,000 | 108,000,000 | 111,000,000 | 142,000,000 | 99,000,000 | 168,000,000 | 147,000,000 | 179,000,000 | 112,000,000 | 66,000,000 | 12,000,000 | |
net cash from investing activities | 22,000,000 | -15,000,000 | 9,000,000 | -4,000,000 | -29,000,000 | -1,000,000 | -31,000,000 | -12,000,000 | -42,000,000 | -73,000,000 | 17,000,000 | -39,000,000 | -3,000,000 | -460,576,000 | ||
cash flows from financing activities: | ||||||||||||||||
payments of issuance costs of the revolving credit facility | 0 | |||||||||||||||
change in customer funds obligations | 4,000,000 | -19,000,000 | 64,000,000 | -4,000,000 | 12,000,000 | -21,000,000 | 49,000,000 | 0 | -4,000,000 | -6,000,000 | 37,000,000 | 0 | -11,000,000 | 10,000,000 | 27,000,000 | -2,002,000 |
proceeds from issuance of common stock | 38,000,000 | 14,000,000 | 26,000,000 | 15,000,000 | 29,000,000 | 27,000,000 | 28,000,000 | 5,000,000 | 16,000,000 | |||||||
warrant repurchase | 0 | |||||||||||||||
repurchases of class a common stock | -23,000,000 | -14,000,000 | -17,000,000 | 0 | -20,000,000 | -32,000,000 | -4,000,000 | |||||||||
net cash from financing activities | 19,000,000 | -22,000,000 | 73,000,000 | 11,000,000 | -40,000,000 | -26,000,000 | 73,000,000 | 5,000,000 | 12,000,000 | -2,000,000 | 48,000,000 | 2,000,000 | -6,000,000 | 13,000,000 | 29,000,000 | 3,086,000 |
effect of exchange rate changes on cash and cash equivalents and restricted cash | 0 | -2,000,000 | 2,000,000 | -817,000 | ||||||||||||
net increase in cash, cash equivalents, cash held on behalf of customers and restricted cash | 180,000,000 | 166,000,000 | 174,000,000 | 142,000,000 | 78,000,000 | 94,000,000 | 24,000,000 | 96,000,000 | 29,000,000 | -90,000,000 | -489,460,000 | |||||
cash, cash equivalents, cash held on behalf of customers and restricted cash at beginning of period | 0 | 0 | 1,085,000,000 | 0 | 0 | 0 | 747,000,000 | 0 | 0 | 0 | 635,000,000 | 0 | 0 | 0 | 851,000,000 | 324,000 |
cash, cash equivalents, cash held on behalf of customers and restricted cash at end of period | 180,000,000 | 166,000,000 | 1,259,000,000 | 141,000,000 | 80,000,000 | 93,000,000 | 771,000,000 | 28,000,000 | 36,000,000 | 586,000,000 | -59,000,000 | -47,000,000 | 830,000,000 | |||
reconciliation of cash, cash equivalents, cash held on behalf of customers and restricted cash | ||||||||||||||||
cash and cash equivalents | 163,000,000 | 189,000,000 | 1,005,000,000 | 142,000,000 | 70,000,000 | 113,000,000 | 578,000,000 | 26,000,000 | 37,000,000 | 451,000,000 | -53,000,000 | -60,000,000 | 757,000,000 | -492,619,000 | ||
cash held on behalf of customers | 4,000,000 | -19,000,000 | 187,000,000 | -4,000,000 | 12,000,000 | -21,000,000 | 136,000,000 | -4,000,000 | -8,000,000 | 99,000,000 | -11,000,000 | 10,000,000 | 62,000,000 | -2,640,000 | ||
restricted cash | 13,000,000 | -4,000,000 | 67,000,000 | -2,000,000 | 1,000,000 | 57,000,000 | 6,000,000 | 7,000,000 | 36,000,000 | 5,000,000 | 3,000,000 | 11,000,000 | 5,306,000 | |||
total cash, cash equivalents, cash held on behalf of customers and restricted cash | 180,000,000 | 166,000,000 | 1,259,000,000 | 80,000,000 | 93,000,000 | 771,000,000 | 28,000,000 | 36,000,000 | 586,000,000 | -59,000,000 | -47,000,000 | 830,000,000 | -489,953,000 | |||
supplemental disclosure of cash flow information: | ||||||||||||||||
stock-based compensation included in capitalized software | 3,000,000 | 3,000,000 | 2,000,000 | |||||||||||||
cash paid for amounts included in the measurement of lease liabilities | 6,000,000 | 4,000,000 | 2,000,000 | |||||||||||||
right-of-use assets obtained in exchange for new operating lease liabilities / (reduction) of lease liabilities from lease terminations and modifications | ||||||||||||||||
net cash (used in) investing activities | ||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | ||||||||||||||||
cash paid for acquisition, net of cash acquired | 0 | 0 | 0 | -9,000,000 | 0 | |||||||||||
other investing activities | 0 | -2,000,000 | 0 | -1,000,000 | ||||||||||||
other financing activities | ||||||||||||||||
change in fair value of derivative liability | -281,000 | |||||||||||||||
loss on debt extinguishment | 217,000 | |||||||||||||||
non-cash interest on convertible notes | ||||||||||||||||
account receivable | ||||||||||||||||
proceeds from initial public offering | ||||||||||||||||
extinguishment of convertible notes | -472,000 | |||||||||||||||
cash, cash equivalents, cash held on behalf of customers and restricted cash at end period | ||||||||||||||||
amortization of deferred costs | 16,000,000 | 14,000,000 | 14,000,000 | 12,000,000 | 12,000,000 | 10,000,000 | 10,000,000 | |||||||||
other | -2,000,000 | 695,000 | ||||||||||||||
prepaid expenses and other current assets | -4,000,000 | 3,000,000 | -6,000,000 | -20,000,000 | -7,000,000 | 2,000,000 | -15,000,000 | -13,133,000 | ||||||||
deferred costs | -27,000,000 | -26,000,000 | -24,000,000 | -18,000,000 | -18,000,000 | -18,000,000 | -17,000,000 | |||||||||
capitalized software | -10,000,000 | -9,000,000 | -8,000,000 | -7,000,000 | -5,000,000 | -4,000,000 | -1,000,000 | -1,288,000 | ||||||||
purchases of property and equipment | 0 | -2,000,000 | -2,000,000 | -3,000,000 | -6,000,000 | -5,000,000 | -2,000,000 | -1,430,000 | ||||||||
payment of contingent consideration | 0 | 0 | 0 | -2,000,000 | ||||||||||||
issuance of class b common stock upon exercise of common stock warrants | 0 | 12,703,000 | ||||||||||||||
change in deferred income taxes | 0 | -1,000,000 | 0 | 920,000 | ||||||||||||
proceeds from exercise of stock options and issuance of common stock upon espp purchase | 11,000,000 | |||||||||||||||
net decrease in cash, cash equivalents, cash held on behalf of customers and restricted cash | -49,000,000 | -47,000,000 | -21,000,000 | |||||||||||||
charitable contribution stock-based expense | ||||||||||||||||
change in fair value of contingent consideration | 1,000,000 | 0 | 0 | 2,000,000 | ||||||||||||
acquired loans and merchant cash advances repaid | ||||||||||||||||
operating lease right-of-use assets | -2,000,000 | -1,000,000 | 5,000,000 | -6,000,000 | ||||||||||||
operating lease liabilities | 2,000,000 | 1,000,000 | -3,000,000 | 4,000,000 | ||||||||||||
payment of deferred offering costs | -956,000 | |||||||||||||||
repayments of secured borrowings | ||||||||||||||||
proceeds from issuance of long-term debt | ||||||||||||||||
proceeds from exercise of stock options | 3,000,000 | 5,000,000 | 3,000,000 | 4,000,000 | 3,273,000 | |||||||||||
proceeds from issuance of restricted stock | ||||||||||||||||
proceeds from issuance of series e and series f preferred | ||||||||||||||||
redemption of series b preferred | ||||||||||||||||
proceeds from exercise of common stock warrants | ||||||||||||||||
change in fair value of warrant liabilities | 21,000,000 | -44,000,000 | -79,000,000 | |||||||||||||
non-cash interest expense on convertible notes | ||||||||||||||||
merchant cash advances and acquired loans repaid | 1,000,000 | 1,000,000 | 1,000,000 | |||||||||||||
purchase of property and equipment included in accounts payable and accrued expenses | 852,000 | |||||||||||||||
stock-based compensation | 53,000,000 | |||||||||||||||
merchant cash advances made | ||||||||||||||||
merchant cash advances repaid | 463,000 | |||||||||||||||
cash paid for acquisition, net of customer funds obligations assumed | ||||||||||||||||
customer funds obligations assumed in acquisition | ||||||||||||||||
purchase of marketable securities | ||||||||||||||||
proceeds from issuance of class a common stock upon initial public offering, net of underwriter discounts | -360,000 | |||||||||||||||
proceeds from secured borrowings | ||||||||||||||||
other proceeds from financing activities | ||||||||||||||||
supplemental disclosure of cash flow information | ||||||||||||||||
cash paid for interest | -226,000 | |||||||||||||||
common stock issued in acquisition | 143,000 | |||||||||||||||
contingent consideration for acquisition included in purchase price | ||||||||||||||||
deferred payment included in purchase price | ||||||||||||||||
conversion of convertible preferred stock into class b common stock upon initial public offering | 107,000 | |||||||||||||||
issuance of common stock warrants upon debt extinguishment | -111,000 | |||||||||||||||
deferred offering costs included in accounts payable and accrued expenses | -1,298,000 | |||||||||||||||
stock-based compensation expense included in capitalized software | ||||||||||||||||
amortization of costs capitalized to obtain revenue contracts | ||||||||||||||||
factor receivable | ||||||||||||||||
costs capitalized to obtain revenue contracts | ||||||||||||||||
proceeds from issuance of series f preferred stock | ||||||||||||||||
proceeds from exercise of restricted stock | ||||||||||||||||
repurchase of restricted stock | ||||||||||||||||
repurchase of common stock | ||||||||||||||||
supplemental disclosures of cash flow information | ||||||||||||||||
non-cash items in investing and financing activities | ||||||||||||||||
contingent consideration included in purchase price | ||||||||||||||||
deferred payments included in purchase price |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
